LeukoTreat aims at developing therapeutic strategies for leukodystrophy (LD) affected patients

Intranet Print the page
Therapeutic strategies for leukodystrophy affected patients - LEUKOTREAT (Home)
Flux RSS des actualités News


Documents to download

All documents prepared by the Ethics Research Group during LeukoTreat ...
See all news

Please enter your e-mail address

Last update : 09/02/2015

LeukoTreat, a collaborative European project on leukodystrophy (2010-2013)

LeukoTreat was a European research and development project funded by the European Commission under the 7th Framework Programme. Gathering 24 partners, the project began on March 1st, 2010 and ended on August 31st, 2013. With the aim of developing therapeutic strategies for the largest number of leukodystrophy (LD) affected patients as well as developing further applications to more common white matter disorders and neurodegenerative diseases, five research axes were pursued during LeukoTreat:

  • The design and development of the LeukoDataBase (LeukoDB), a European data base including clinical and biological data of more than 500 patients
  • The identification of Biomarkers for leukodystrophies treatment
  • The development of Pharmacological strategies to treat leukodystrophies
  • The development of Gene and cell therapies in leukodystrophies
  • Ethics, notably in relation to the LeukoDB


Hereafter, main documents stemming from LeukoTreat can be downloaded:

LeukoTreat Partners - Kick-off Meeting

Etoiles de l'Europe 2014 trophy


On December 16th, 2014, Odile Boespflug-Tanguy (UPD-P7, LeukoTreat Coordinator) was awarded with the “Etoiles de l’Europe” trophy by the French State Secretariat for Higher Education and Research.

Created in 2013, this trophy aims at promoting EU-funded projects research teams and coordinators for their European commitment and their work as project leaders. 12 French-coordinated European projects which were successfully concluded in the past year are thus selected annually and granted this award.

Amongst main criteria for receiving the trophy is notably the quality of the scientific production stemming from the EU-funded project, the subsequent value creation, as well as societal implications of the project.